secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001628280-26-001746
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics prelim Q4 rev $190M (+11% YoY), FY rev $727M (+10%); CFO Sherman retiring, Jain appointed
--------------------------------------------------------------------------------

- Preliminary Q4 2025 revenue ~$190M (+11% YoY); full-year 2025 revenue ~$727M (+10% YoY).
- CFO Jeff Sherman to retire; will become EVP Finance on March 2, 2026, then special adviser through April 2028.
- Abhishek Jain joins as EVP Finance Jan 12, 2026; to assume CFO role on March 2, 2026.
- Jain's compensation: base salary $520K, target bonus 60% of salary, initial equity grant $2.75M (RSUs and options).
- Results are preliminary and subject to change; final results expected in February 2026 earnings call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026001746/0001628280-26-001746-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000162828026001746/neo-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-001746

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer